Global Hemostats Supply, Demand and Key Producers, 2024-2030

Global Hemostats Supply, Demand and Key Producers, 2024-2030

Page: 141

Published Date: 20 Feb 2024

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Hemostats market size is expected to reach $ 4149.5 million by 2030, rising at a market growth of 5.6% CAGR during the forecast period (2024-2030).

Global Hemostats key players include Ethicon, Inc., Pfizer, Inc., Baxter International Inc., C. R. Bard, The Medicines Company, etc. Global top five manufacturers hold a share over 55%.

North America is the largest market, with a share about 35%, followed by China, and Europe, both have a share over 35 percent.

In terms of product, Thrombin-Based Hemostats is the largest segment, with a share over 40%. And in terms of application, the largest application is Hospital Treatment, followed by Prehospital Treatment, etc.

Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.

This report studies the global Hemostats production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Hemostats, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hemostats that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Hemostats total production and demand, 2019-2030, (K Pcs)
Global Hemostats total production value, 2019-2030, (USD Million)
Global Hemostats production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Pcs)
Global Hemostats consumption by region & country, CAGR, 2019-2030 & (K Pcs)
U.S. VS China: Hemostats domestic production, consumption, key domestic manufacturers and share
Global Hemostats production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Pcs)
Global Hemostats production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Pcs)
Global Hemostats production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Pcs).

This reports profiles key players in the global Hemostats market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ethicon, Pfizer, Baxter International Inc., C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences Corporation and B Braun Melsungen AG, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hemostats market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Pcs) and average price (USD/Pcs) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Hemostats Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Hemostats Market, Segmentation by Type
Thrombin-Based Hemostats
Oxidized Regenerated Cellulose Based Hemostats
Combination Hemostats
Gelatin Based Hemostats
Collagen Based Hemostats

Global Hemostats Market, Segmentation by Application
Prehospital Treatment
Hospital Treatment

Companies Profiled:
Ethicon
Pfizer
Baxter International Inc.
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences Corporation
B Braun Melsungen AG
Gelita Medical GmbH
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica, LLC
CryoLife
BioCer Entwicklungs-GmbH.
Biom'Up SAS

Key Questions Answered
1. How big is the global Hemostats market?
2. What is the demand of the global Hemostats market?
3. What is the year over year growth of the global Hemostats market?
4. What is the production and production value of the global Hemostats market?
5. Who are the key producers in the global Hemostats market?
btl

Table of Contents

1 Supply Summary
1.1 Hemostats Introduction
1.2 World Hemostats Supply & Forecast
1.2.1 World Hemostats Production Value (2019 & 2023 & 2030)
1.2.2 World Hemostats Production (2019-2030)
1.2.3 World Hemostats Pricing Trends (2019-2030)
1.3 World Hemostats Production by Region (Based on Production Site)
1.3.1 World Hemostats Production Value by Region (2019-2030)
1.3.2 World Hemostats Production by Region (2019-2030)
1.3.3 World Hemostats Average Price by Region (2019-2030)
1.3.4 North America Hemostats Production (2019-2030)
1.3.5 Europe Hemostats Production (2019-2030)
1.3.6 China Hemostats Production (2019-2030)
1.3.7 Japan Hemostats Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Hemostats Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Hemostats Major Market Trends

2 Demand Summary
2.1 World Hemostats Demand (2019-2030)
2.2 World Hemostats Consumption by Region
2.2.1 World Hemostats Consumption by Region (2019-2024)
2.2.2 World Hemostats Consumption Forecast by Region (2025-2030)
2.3 United States Hemostats Consumption (2019-2030)
2.4 China Hemostats Consumption (2019-2030)
2.5 Europe Hemostats Consumption (2019-2030)
2.6 Japan Hemostats Consumption (2019-2030)
2.7 South Korea Hemostats Consumption (2019-2030)
2.8 ASEAN Hemostats Consumption (2019-2030)
2.9 India Hemostats Consumption (2019-2030)

3 World Hemostats Manufacturers Competitive Analysis
3.1 World Hemostats Production Value by Manufacturer (2019-2024)
3.2 World Hemostats Production by Manufacturer (2019-2024)
3.3 World Hemostats Average Price by Manufacturer (2019-2024)
3.4 Hemostats Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Hemostats Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Hemostats in 2023
3.5.3 Global Concentration Ratios (CR8) for Hemostats in 2023
3.6 Hemostats Market: Overall Company Footprint Analysis
3.6.1 Hemostats Market: Region Footprint
3.6.2 Hemostats Market: Company Product Type Footprint
3.6.3 Hemostats Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Hemostats Production Value Comparison
4.1.1 United States VS China: Hemostats Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Hemostats Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Hemostats Production Comparison
4.2.1 United States VS China: Hemostats Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Hemostats Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Hemostats Consumption Comparison
4.3.1 United States VS China: Hemostats Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Hemostats Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Hemostats Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Hemostats Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Hemostats Production Value (2019-2024)
4.4.3 United States Based Manufacturers Hemostats Production (2019-2024)
4.5 China Based Hemostats Manufacturers and Market Share
4.5.1 China Based Hemostats Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Hemostats Production Value (2019-2024)
4.5.3 China Based Manufacturers Hemostats Production (2019-2024)
4.6 Rest of World Based Hemostats Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Hemostats Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Hemostats Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Hemostats Production (2019-2024)

5 Market Analysis by Type
5.1 World Hemostats Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Thrombin-Based Hemostats
5.2.2 Oxidized Regenerated Cellulose Based Hemostats
5.2.3 Combination Hemostats
5.2.4 Gelatin Based Hemostats
5.2.5 Collagen Based Hemostats
5.3 Market Segment by Type
5.3.1 World Hemostats Production by Type (2019-2030)
5.3.2 World Hemostats Production Value by Type (2019-2030)
5.3.3 World Hemostats Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Hemostats Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Prehospital Treatment
6.2.2 Hospital Treatment
6.3 Market Segment by Application
6.3.1 World Hemostats Production by Application (2019-2030)
6.3.2 World Hemostats Production Value by Application (2019-2030)
6.3.3 World Hemostats Average Price by Application (2019-2030)

7 Company Profiles
7.1 Ethicon
7.1.1 Ethicon Details
7.1.2 Ethicon Major Business
7.1.3 Ethicon Hemostats Product and Services
7.1.4 Ethicon Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Ethicon Recent Developments/Updates
7.1.6 Ethicon Competitive Strengths & Weaknesses
7.2 Pfizer
7.2.1 Pfizer Details
7.2.2 Pfizer Major Business
7.2.3 Pfizer Hemostats Product and Services
7.2.4 Pfizer Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Pfizer Recent Developments/Updates
7.2.6 Pfizer Competitive Strengths & Weaknesses
7.3 Baxter International Inc.
7.3.1 Baxter International Inc. Details
7.3.2 Baxter International Inc. Major Business
7.3.3 Baxter International Inc. Hemostats Product and Services
7.3.4 Baxter International Inc. Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Baxter International Inc. Recent Developments/Updates
7.3.6 Baxter International Inc. Competitive Strengths & Weaknesses
7.4 C. R. Bard
7.4.1 C. R. Bard Details
7.4.2 C. R. Bard Major Business
7.4.3 C. R. Bard Hemostats Product and Services
7.4.4 C. R. Bard Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 C. R. Bard Recent Developments/Updates
7.4.6 C. R. Bard Competitive Strengths & Weaknesses
7.5 The Medicines Company
7.5.1 The Medicines Company Details
7.5.2 The Medicines Company Major Business
7.5.3 The Medicines Company Hemostats Product and Services
7.5.4 The Medicines Company Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 The Medicines Company Recent Developments/Updates
7.5.6 The Medicines Company Competitive Strengths & Weaknesses
7.6 Anika Therapeutics
7.6.1 Anika Therapeutics Details
7.6.2 Anika Therapeutics Major Business
7.6.3 Anika Therapeutics Hemostats Product and Services
7.6.4 Anika Therapeutics Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Anika Therapeutics Recent Developments/Updates
7.6.6 Anika Therapeutics Competitive Strengths & Weaknesses
7.7 Advanced Medical Solutions
7.7.1 Advanced Medical Solutions Details
7.7.2 Advanced Medical Solutions Major Business
7.7.3 Advanced Medical Solutions Hemostats Product and Services
7.7.4 Advanced Medical Solutions Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Advanced Medical Solutions Recent Developments/Updates
7.7.6 Advanced Medical Solutions Competitive Strengths & Weaknesses
7.8 Integra LifeSciences Corporation
7.8.1 Integra LifeSciences Corporation Details
7.8.2 Integra LifeSciences Corporation Major Business
7.8.3 Integra LifeSciences Corporation Hemostats Product and Services
7.8.4 Integra LifeSciences Corporation Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Integra LifeSciences Corporation Recent Developments/Updates
7.8.6 Integra LifeSciences Corporation Competitive Strengths & Weaknesses
7.9 B Braun Melsungen AG
7.9.1 B Braun Melsungen AG Details
7.9.2 B Braun Melsungen AG Major Business
7.9.3 B Braun Melsungen AG Hemostats Product and Services
7.9.4 B Braun Melsungen AG Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 B Braun Melsungen AG Recent Developments/Updates
7.9.6 B Braun Melsungen AG Competitive Strengths & Weaknesses
7.10 Gelita Medical GmbH
7.10.1 Gelita Medical GmbH Details
7.10.2 Gelita Medical GmbH Major Business
7.10.3 Gelita Medical GmbH Hemostats Product and Services
7.10.4 Gelita Medical GmbH Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Gelita Medical GmbH Recent Developments/Updates
7.10.6 Gelita Medical GmbH Competitive Strengths & Weaknesses
7.11 Equimedical
7.11.1 Equimedical Details
7.11.2 Equimedical Major Business
7.11.3 Equimedical Hemostats Product and Services
7.11.4 Equimedical Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Equimedical Recent Developments/Updates
7.11.6 Equimedical Competitive Strengths & Weaknesses
7.12 Vascular Solutions
7.12.1 Vascular Solutions Details
7.12.2 Vascular Solutions Major Business
7.12.3 Vascular Solutions Hemostats Product and Services
7.12.4 Vascular Solutions Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Vascular Solutions Recent Developments/Updates
7.12.6 Vascular Solutions Competitive Strengths & Weaknesses
7.13 Marine Polymer Technologies
7.13.1 Marine Polymer Technologies Details
7.13.2 Marine Polymer Technologies Major Business
7.13.3 Marine Polymer Technologies Hemostats Product and Services
7.13.4 Marine Polymer Technologies Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Marine Polymer Technologies Recent Developments/Updates
7.13.6 Marine Polymer Technologies Competitive Strengths & Weaknesses
7.14 Z-Medica, LLC
7.14.1 Z-Medica, LLC Details
7.14.2 Z-Medica, LLC Major Business
7.14.3 Z-Medica, LLC Hemostats Product and Services
7.14.4 Z-Medica, LLC Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 Z-Medica, LLC Recent Developments/Updates
7.14.6 Z-Medica, LLC Competitive Strengths & Weaknesses
7.15 CryoLife
7.15.1 CryoLife Details
7.15.2 CryoLife Major Business
7.15.3 CryoLife Hemostats Product and Services
7.15.4 CryoLife Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 CryoLife Recent Developments/Updates
7.15.6 CryoLife Competitive Strengths & Weaknesses
7.16 BioCer Entwicklungs-GmbH.
7.16.1 BioCer Entwicklungs-GmbH. Details
7.16.2 BioCer Entwicklungs-GmbH. Major Business
7.16.3 BioCer Entwicklungs-GmbH. Hemostats Product and Services
7.16.4 BioCer Entwicklungs-GmbH. Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 BioCer Entwicklungs-GmbH. Recent Developments/Updates
7.16.6 BioCer Entwicklungs-GmbH. Competitive Strengths & Weaknesses
7.17 Biom'Up SAS
7.17.1 Biom'Up SAS Details
7.17.2 Biom'Up SAS Major Business
7.17.3 Biom'Up SAS Hemostats Product and Services
7.17.4 Biom'Up SAS Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.17.5 Biom'Up SAS Recent Developments/Updates
7.17.6 Biom'Up SAS Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Hemostats Industry Chain
8.2 Hemostats Upstream Analysis
8.2.1 Hemostats Core Raw Materials
8.2.2 Main Manufacturers of Hemostats Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Hemostats Production Mode
8.6 Hemostats Procurement Model
8.7 Hemostats Industry Sales Model and Sales Channels
8.7.1 Hemostats Sales Model
8.7.2 Hemostats Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Hemostats Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Hemostats Production Value by Region (2019-2024) & (USD Million)
Table 3. World Hemostats Production Value by Region (2025-2030) & (USD Million)
Table 4. World Hemostats Production Value Market Share by Region (2019-2024)
Table 5. World Hemostats Production Value Market Share by Region (2025-2030)
Table 6. World Hemostats Production by Region (2019-2024) & (K Pcs)
Table 7. World Hemostats Production by Region (2025-2030) & (K Pcs)
Table 8. World Hemostats Production Market Share by Region (2019-2024)
Table 9. World Hemostats Production Market Share by Region (2025-2030)
Table 10. World Hemostats Average Price by Region (2019-2024) & (USD/Pcs)
Table 11. World Hemostats Average Price by Region (2025-2030) & (USD/Pcs)
Table 12. Hemostats Major Market Trends
Table 13. World Hemostats Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Pcs)
Table 14. World Hemostats Consumption by Region (2019-2024) & (K Pcs)
Table 15. World Hemostats Consumption Forecast by Region (2025-2030) & (K Pcs)
Table 16. World Hemostats Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Hemostats Producers in 2023
Table 18. World Hemostats Production by Manufacturer (2019-2024) & (K Pcs)
Table 19. Production Market Share of Key Hemostats Producers in 2023
Table 20. World Hemostats Average Price by Manufacturer (2019-2024) & (USD/Pcs)
Table 21. Global Hemostats Company Evaluation Quadrant
Table 22. World Hemostats Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Hemostats Production Site of Key Manufacturer
Table 24. Hemostats Market: Company Product Type Footprint
Table 25. Hemostats Market: Company Product Application Footprint
Table 26. Hemostats Competitive Factors
Table 27. Hemostats New Entrant and Capacity Expansion Plans
Table 28. Hemostats Mergers & Acquisitions Activity
Table 29. United States VS China Hemostats Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Hemostats Production Comparison, (2019 & 2023 & 2030) & (K Pcs)
Table 31. United States VS China Hemostats Consumption Comparison, (2019 & 2023 & 2030) & (K Pcs)
Table 32. United States Based Hemostats Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Hemostats Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Hemostats Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Hemostats Production (2019-2024) & (K Pcs)
Table 36. United States Based Manufacturers Hemostats Production Market Share (2019-2024)
Table 37. China Based Hemostats Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Hemostats Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Hemostats Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Hemostats Production (2019-2024) & (K Pcs)
Table 41. China Based Manufacturers Hemostats Production Market Share (2019-2024)
Table 42. Rest of World Based Hemostats Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Hemostats Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Hemostats Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Hemostats Production (2019-2024) & (K Pcs)
Table 46. Rest of World Based Manufacturers Hemostats Production Market Share (2019-2024)
Table 47. World Hemostats Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Hemostats Production by Type (2019-2024) & (K Pcs)
Table 49. World Hemostats Production by Type (2025-2030) & (K Pcs)
Table 50. World Hemostats Production Value by Type (2019-2024) & (USD Million)
Table 51. World Hemostats Production Value by Type (2025-2030) & (USD Million)
Table 52. World Hemostats Average Price by Type (2019-2024) & (USD/Pcs)
Table 53. World Hemostats Average Price by Type (2025-2030) & (USD/Pcs)
Table 54. World Hemostats Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Hemostats Production by Application (2019-2024) & (K Pcs)
Table 56. World Hemostats Production by Application (2025-2030) & (K Pcs)
Table 57. World Hemostats Production Value by Application (2019-2024) & (USD Million)
Table 58. World Hemostats Production Value by Application (2025-2030) & (USD Million)
Table 59. World Hemostats Average Price by Application (2019-2024) & (USD/Pcs)
Table 60. World Hemostats Average Price by Application (2025-2030) & (USD/Pcs)
Table 61. Ethicon Basic Information, Manufacturing Base and Competitors
Table 62. Ethicon Major Business
Table 63. Ethicon Hemostats Product and Services
Table 64. Ethicon Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Ethicon Recent Developments/Updates
Table 66. Ethicon Competitive Strengths & Weaknesses
Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Major Business
Table 69. Pfizer Hemostats Product and Services
Table 70. Pfizer Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Pfizer Recent Developments/Updates
Table 72. Pfizer Competitive Strengths & Weaknesses
Table 73. Baxter International Inc. Basic Information, Manufacturing Base and Competitors
Table 74. Baxter International Inc. Major Business
Table 75. Baxter International Inc. Hemostats Product and Services
Table 76. Baxter International Inc. Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Baxter International Inc. Recent Developments/Updates
Table 78. Baxter International Inc. Competitive Strengths & Weaknesses
Table 79. C. R. Bard Basic Information, Manufacturing Base and Competitors
Table 80. C. R. Bard Major Business
Table 81. C. R. Bard Hemostats Product and Services
Table 82. C. R. Bard Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. C. R. Bard Recent Developments/Updates
Table 84. C. R. Bard Competitive Strengths & Weaknesses
Table 85. The Medicines Company Basic Information, Manufacturing Base and Competitors
Table 86. The Medicines Company Major Business
Table 87. The Medicines Company Hemostats Product and Services
Table 88. The Medicines Company Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. The Medicines Company Recent Developments/Updates
Table 90. The Medicines Company Competitive Strengths & Weaknesses
Table 91. Anika Therapeutics Basic Information, Manufacturing Base and Competitors
Table 92. Anika Therapeutics Major Business
Table 93. Anika Therapeutics Hemostats Product and Services
Table 94. Anika Therapeutics Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Anika Therapeutics Recent Developments/Updates
Table 96. Anika Therapeutics Competitive Strengths & Weaknesses
Table 97. Advanced Medical Solutions Basic Information, Manufacturing Base and Competitors
Table 98. Advanced Medical Solutions Major Business
Table 99. Advanced Medical Solutions Hemostats Product and Services
Table 100. Advanced Medical Solutions Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Advanced Medical Solutions Recent Developments/Updates
Table 102. Advanced Medical Solutions Competitive Strengths & Weaknesses
Table 103. Integra LifeSciences Corporation Basic Information, Manufacturing Base and Competitors
Table 104. Integra LifeSciences Corporation Major Business
Table 105. Integra LifeSciences Corporation Hemostats Product and Services
Table 106. Integra LifeSciences Corporation Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Integra LifeSciences Corporation Recent Developments/Updates
Table 108. Integra LifeSciences Corporation Competitive Strengths & Weaknesses
Table 109. B Braun Melsungen AG Basic Information, Manufacturing Base and Competitors
Table 110. B Braun Melsungen AG Major Business
Table 111. B Braun Melsungen AG Hemostats Product and Services
Table 112. B Braun Melsungen AG Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. B Braun Melsungen AG Recent Developments/Updates
Table 114. B Braun Melsungen AG Competitive Strengths & Weaknesses
Table 115. Gelita Medical GmbH Basic Information, Manufacturing Base and Competitors
Table 116. Gelita Medical GmbH Major Business
Table 117. Gelita Medical GmbH Hemostats Product and Services
Table 118. Gelita Medical GmbH Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Gelita Medical GmbH Recent Developments/Updates
Table 120. Gelita Medical GmbH Competitive Strengths & Weaknesses
Table 121. Equimedical Basic Information, Manufacturing Base and Competitors
Table 122. Equimedical Major Business
Table 123. Equimedical Hemostats Product and Services
Table 124. Equimedical Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Equimedical Recent Developments/Updates
Table 126. Equimedical Competitive Strengths & Weaknesses
Table 127. Vascular Solutions Basic Information, Manufacturing Base and Competitors
Table 128. Vascular Solutions Major Business
Table 129. Vascular Solutions Hemostats Product and Services
Table 130. Vascular Solutions Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Vascular Solutions Recent Developments/Updates
Table 132. Vascular Solutions Competitive Strengths & Weaknesses
Table 133. Marine Polymer Technologies Basic Information, Manufacturing Base and Competitors
Table 134. Marine Polymer Technologies Major Business
Table 135. Marine Polymer Technologies Hemostats Product and Services
Table 136. Marine Polymer Technologies Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. Marine Polymer Technologies Recent Developments/Updates
Table 138. Marine Polymer Technologies Competitive Strengths & Weaknesses
Table 139. Z-Medica, LLC Basic Information, Manufacturing Base and Competitors
Table 140. Z-Medica, LLC Major Business
Table 141. Z-Medica, LLC Hemostats Product and Services
Table 142. Z-Medica, LLC Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. Z-Medica, LLC Recent Developments/Updates
Table 144. Z-Medica, LLC Competitive Strengths & Weaknesses
Table 145. CryoLife Basic Information, Manufacturing Base and Competitors
Table 146. CryoLife Major Business
Table 147. CryoLife Hemostats Product and Services
Table 148. CryoLife Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. CryoLife Recent Developments/Updates
Table 150. CryoLife Competitive Strengths & Weaknesses
Table 151. BioCer Entwicklungs-GmbH. Basic Information, Manufacturing Base and Competitors
Table 152. BioCer Entwicklungs-GmbH. Major Business
Table 153. BioCer Entwicklungs-GmbH. Hemostats Product and Services
Table 154. BioCer Entwicklungs-GmbH. Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 155. BioCer Entwicklungs-GmbH. Recent Developments/Updates
Table 156. Biom'Up SAS Basic Information, Manufacturing Base and Competitors
Table 157. Biom'Up SAS Major Business
Table 158. Biom'Up SAS Hemostats Product and Services
Table 159. Biom'Up SAS Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 160. Global Key Players of Hemostats Upstream (Raw Materials)
Table 161. Hemostats Typical Customers
Table 162. Hemostats Typical Distributors
List of Figure
Figure 1. Hemostats Picture
Figure 2. World Hemostats Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Hemostats Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Hemostats Production (2019-2030) & (K Pcs)
Figure 5. World Hemostats Average Price (2019-2030) & (USD/Pcs)
Figure 6. World Hemostats Production Value Market Share by Region (2019-2030)
Figure 7. World Hemostats Production Market Share by Region (2019-2030)
Figure 8. North America Hemostats Production (2019-2030) & (K Pcs)
Figure 9. Europe Hemostats Production (2019-2030) & (K Pcs)
Figure 10. China Hemostats Production (2019-2030) & (K Pcs)
Figure 11. Japan Hemostats Production (2019-2030) & (K Pcs)
Figure 12. Hemostats Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Hemostats Consumption (2019-2030) & (K Pcs)
Figure 15. World Hemostats Consumption Market Share by Region (2019-2030)
Figure 16. United States Hemostats Consumption (2019-2030) & (K Pcs)
Figure 17. China Hemostats Consumption (2019-2030) & (K Pcs)
Figure 18. Europe Hemostats Consumption (2019-2030) & (K Pcs)
Figure 19. Japan Hemostats Consumption (2019-2030) & (K Pcs)
Figure 20. South Korea Hemostats Consumption (2019-2030) & (K Pcs)
Figure 21. ASEAN Hemostats Consumption (2019-2030) & (K Pcs)
Figure 22. India Hemostats Consumption (2019-2030) & (K Pcs)
Figure 23. Producer Shipments of Hemostats by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Hemostats Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Hemostats Markets in 2023
Figure 26. United States VS China: Hemostats Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Hemostats Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Hemostats Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Hemostats Production Market Share 2023
Figure 30. China Based Manufacturers Hemostats Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Hemostats Production Market Share 2023
Figure 32. World Hemostats Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Hemostats Production Value Market Share by Type in 2023
Figure 34. Thrombin-Based Hemostats
Figure 35. Oxidized Regenerated Cellulose Based Hemostats
Figure 36. Combination Hemostats
Figure 37. Gelatin Based Hemostats
Figure 38. Collagen Based Hemostats
Figure 39. World Hemostats Production Market Share by Type (2019-2030)
Figure 40. World Hemostats Production Value Market Share by Type (2019-2030)
Figure 41. World Hemostats Average Price by Type (2019-2030) & (USD/Pcs)
Figure 42. World Hemostats Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 43. World Hemostats Production Value Market Share by Application in 2023
Figure 44. Prehospital Treatment
Figure 45. Hospital Treatment
Figure 46. World Hemostats Production Market Share by Application (2019-2030)
Figure 47. World Hemostats Production Value Market Share by Application (2019-2030)
Figure 48. World Hemostats Average Price by Application (2019-2030) & (USD/Pcs)
Figure 49. Hemostats Industry Chain
Figure 50. Hemostats Procurement Model
Figure 51. Hemostats Sales Model
Figure 52. Hemostats Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Ethicon
Pfizer
Baxter International Inc.
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences Corporation
B Braun Melsungen AG
Gelita Medical GmbH
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica, LLC
CryoLife
BioCer Entwicklungs-GmbH.
Biom'Up SAS
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Hemostats Supply, Demand and Key Producers, 2024-2030

Global Hemostats Supply, Demand and Key Producers, 2024-2030

Page: 141

Published Date: 20 Feb 2024

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Hemostats market size is expected to reach $ 4149.5 million by 2030, rising at a market growth of 5.6% CAGR during the forecast period (2024-2030).

Global Hemostats key players include Ethicon, Inc., Pfizer, Inc., Baxter International Inc., C. R. Bard, The Medicines Company, etc. Global top five manufacturers hold a share over 55%.

North America is the largest market, with a share about 35%, followed by China, and Europe, both have a share over 35 percent.

In terms of product, Thrombin-Based Hemostats is the largest segment, with a share over 40%. And in terms of application, the largest application is Hospital Treatment, followed by Prehospital Treatment, etc.

Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.

This report studies the global Hemostats production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Hemostats, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hemostats that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Hemostats total production and demand, 2019-2030, (K Pcs)
Global Hemostats total production value, 2019-2030, (USD Million)
Global Hemostats production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Pcs)
Global Hemostats consumption by region & country, CAGR, 2019-2030 & (K Pcs)
U.S. VS China: Hemostats domestic production, consumption, key domestic manufacturers and share
Global Hemostats production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Pcs)
Global Hemostats production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Pcs)
Global Hemostats production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Pcs).

This reports profiles key players in the global Hemostats market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ethicon, Pfizer, Baxter International Inc., C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences Corporation and B Braun Melsungen AG, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hemostats market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Pcs) and average price (USD/Pcs) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Hemostats Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Hemostats Market, Segmentation by Type
Thrombin-Based Hemostats
Oxidized Regenerated Cellulose Based Hemostats
Combination Hemostats
Gelatin Based Hemostats
Collagen Based Hemostats

Global Hemostats Market, Segmentation by Application
Prehospital Treatment
Hospital Treatment

Companies Profiled:
Ethicon
Pfizer
Baxter International Inc.
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences Corporation
B Braun Melsungen AG
Gelita Medical GmbH
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica, LLC
CryoLife
BioCer Entwicklungs-GmbH.
Biom'Up SAS

Key Questions Answered
1. How big is the global Hemostats market?
2. What is the demand of the global Hemostats market?
3. What is the year over year growth of the global Hemostats market?
4. What is the production and production value of the global Hemostats market?
5. Who are the key producers in the global Hemostats market?
btl

Table of Contents

1 Supply Summary
1.1 Hemostats Introduction
1.2 World Hemostats Supply & Forecast
1.2.1 World Hemostats Production Value (2019 & 2023 & 2030)
1.2.2 World Hemostats Production (2019-2030)
1.2.3 World Hemostats Pricing Trends (2019-2030)
1.3 World Hemostats Production by Region (Based on Production Site)
1.3.1 World Hemostats Production Value by Region (2019-2030)
1.3.2 World Hemostats Production by Region (2019-2030)
1.3.3 World Hemostats Average Price by Region (2019-2030)
1.3.4 North America Hemostats Production (2019-2030)
1.3.5 Europe Hemostats Production (2019-2030)
1.3.6 China Hemostats Production (2019-2030)
1.3.7 Japan Hemostats Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Hemostats Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Hemostats Major Market Trends

2 Demand Summary
2.1 World Hemostats Demand (2019-2030)
2.2 World Hemostats Consumption by Region
2.2.1 World Hemostats Consumption by Region (2019-2024)
2.2.2 World Hemostats Consumption Forecast by Region (2025-2030)
2.3 United States Hemostats Consumption (2019-2030)
2.4 China Hemostats Consumption (2019-2030)
2.5 Europe Hemostats Consumption (2019-2030)
2.6 Japan Hemostats Consumption (2019-2030)
2.7 South Korea Hemostats Consumption (2019-2030)
2.8 ASEAN Hemostats Consumption (2019-2030)
2.9 India Hemostats Consumption (2019-2030)

3 World Hemostats Manufacturers Competitive Analysis
3.1 World Hemostats Production Value by Manufacturer (2019-2024)
3.2 World Hemostats Production by Manufacturer (2019-2024)
3.3 World Hemostats Average Price by Manufacturer (2019-2024)
3.4 Hemostats Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Hemostats Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Hemostats in 2023
3.5.3 Global Concentration Ratios (CR8) for Hemostats in 2023
3.6 Hemostats Market: Overall Company Footprint Analysis
3.6.1 Hemostats Market: Region Footprint
3.6.2 Hemostats Market: Company Product Type Footprint
3.6.3 Hemostats Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Hemostats Production Value Comparison
4.1.1 United States VS China: Hemostats Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Hemostats Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Hemostats Production Comparison
4.2.1 United States VS China: Hemostats Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Hemostats Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Hemostats Consumption Comparison
4.3.1 United States VS China: Hemostats Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Hemostats Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Hemostats Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Hemostats Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Hemostats Production Value (2019-2024)
4.4.3 United States Based Manufacturers Hemostats Production (2019-2024)
4.5 China Based Hemostats Manufacturers and Market Share
4.5.1 China Based Hemostats Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Hemostats Production Value (2019-2024)
4.5.3 China Based Manufacturers Hemostats Production (2019-2024)
4.6 Rest of World Based Hemostats Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Hemostats Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Hemostats Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Hemostats Production (2019-2024)

5 Market Analysis by Type
5.1 World Hemostats Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Thrombin-Based Hemostats
5.2.2 Oxidized Regenerated Cellulose Based Hemostats
5.2.3 Combination Hemostats
5.2.4 Gelatin Based Hemostats
5.2.5 Collagen Based Hemostats
5.3 Market Segment by Type
5.3.1 World Hemostats Production by Type (2019-2030)
5.3.2 World Hemostats Production Value by Type (2019-2030)
5.3.3 World Hemostats Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Hemostats Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Prehospital Treatment
6.2.2 Hospital Treatment
6.3 Market Segment by Application
6.3.1 World Hemostats Production by Application (2019-2030)
6.3.2 World Hemostats Production Value by Application (2019-2030)
6.3.3 World Hemostats Average Price by Application (2019-2030)

7 Company Profiles
7.1 Ethicon
7.1.1 Ethicon Details
7.1.2 Ethicon Major Business
7.1.3 Ethicon Hemostats Product and Services
7.1.4 Ethicon Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Ethicon Recent Developments/Updates
7.1.6 Ethicon Competitive Strengths & Weaknesses
7.2 Pfizer
7.2.1 Pfizer Details
7.2.2 Pfizer Major Business
7.2.3 Pfizer Hemostats Product and Services
7.2.4 Pfizer Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Pfizer Recent Developments/Updates
7.2.6 Pfizer Competitive Strengths & Weaknesses
7.3 Baxter International Inc.
7.3.1 Baxter International Inc. Details
7.3.2 Baxter International Inc. Major Business
7.3.3 Baxter International Inc. Hemostats Product and Services
7.3.4 Baxter International Inc. Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Baxter International Inc. Recent Developments/Updates
7.3.6 Baxter International Inc. Competitive Strengths & Weaknesses
7.4 C. R. Bard
7.4.1 C. R. Bard Details
7.4.2 C. R. Bard Major Business
7.4.3 C. R. Bard Hemostats Product and Services
7.4.4 C. R. Bard Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 C. R. Bard Recent Developments/Updates
7.4.6 C. R. Bard Competitive Strengths & Weaknesses
7.5 The Medicines Company
7.5.1 The Medicines Company Details
7.5.2 The Medicines Company Major Business
7.5.3 The Medicines Company Hemostats Product and Services
7.5.4 The Medicines Company Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 The Medicines Company Recent Developments/Updates
7.5.6 The Medicines Company Competitive Strengths & Weaknesses
7.6 Anika Therapeutics
7.6.1 Anika Therapeutics Details
7.6.2 Anika Therapeutics Major Business
7.6.3 Anika Therapeutics Hemostats Product and Services
7.6.4 Anika Therapeutics Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Anika Therapeutics Recent Developments/Updates
7.6.6 Anika Therapeutics Competitive Strengths & Weaknesses
7.7 Advanced Medical Solutions
7.7.1 Advanced Medical Solutions Details
7.7.2 Advanced Medical Solutions Major Business
7.7.3 Advanced Medical Solutions Hemostats Product and Services
7.7.4 Advanced Medical Solutions Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Advanced Medical Solutions Recent Developments/Updates
7.7.6 Advanced Medical Solutions Competitive Strengths & Weaknesses
7.8 Integra LifeSciences Corporation
7.8.1 Integra LifeSciences Corporation Details
7.8.2 Integra LifeSciences Corporation Major Business
7.8.3 Integra LifeSciences Corporation Hemostats Product and Services
7.8.4 Integra LifeSciences Corporation Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Integra LifeSciences Corporation Recent Developments/Updates
7.8.6 Integra LifeSciences Corporation Competitive Strengths & Weaknesses
7.9 B Braun Melsungen AG
7.9.1 B Braun Melsungen AG Details
7.9.2 B Braun Melsungen AG Major Business
7.9.3 B Braun Melsungen AG Hemostats Product and Services
7.9.4 B Braun Melsungen AG Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 B Braun Melsungen AG Recent Developments/Updates
7.9.6 B Braun Melsungen AG Competitive Strengths & Weaknesses
7.10 Gelita Medical GmbH
7.10.1 Gelita Medical GmbH Details
7.10.2 Gelita Medical GmbH Major Business
7.10.3 Gelita Medical GmbH Hemostats Product and Services
7.10.4 Gelita Medical GmbH Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Gelita Medical GmbH Recent Developments/Updates
7.10.6 Gelita Medical GmbH Competitive Strengths & Weaknesses
7.11 Equimedical
7.11.1 Equimedical Details
7.11.2 Equimedical Major Business
7.11.3 Equimedical Hemostats Product and Services
7.11.4 Equimedical Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Equimedical Recent Developments/Updates
7.11.6 Equimedical Competitive Strengths & Weaknesses
7.12 Vascular Solutions
7.12.1 Vascular Solutions Details
7.12.2 Vascular Solutions Major Business
7.12.3 Vascular Solutions Hemostats Product and Services
7.12.4 Vascular Solutions Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Vascular Solutions Recent Developments/Updates
7.12.6 Vascular Solutions Competitive Strengths & Weaknesses
7.13 Marine Polymer Technologies
7.13.1 Marine Polymer Technologies Details
7.13.2 Marine Polymer Technologies Major Business
7.13.3 Marine Polymer Technologies Hemostats Product and Services
7.13.4 Marine Polymer Technologies Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Marine Polymer Technologies Recent Developments/Updates
7.13.6 Marine Polymer Technologies Competitive Strengths & Weaknesses
7.14 Z-Medica, LLC
7.14.1 Z-Medica, LLC Details
7.14.2 Z-Medica, LLC Major Business
7.14.3 Z-Medica, LLC Hemostats Product and Services
7.14.4 Z-Medica, LLC Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 Z-Medica, LLC Recent Developments/Updates
7.14.6 Z-Medica, LLC Competitive Strengths & Weaknesses
7.15 CryoLife
7.15.1 CryoLife Details
7.15.2 CryoLife Major Business
7.15.3 CryoLife Hemostats Product and Services
7.15.4 CryoLife Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 CryoLife Recent Developments/Updates
7.15.6 CryoLife Competitive Strengths & Weaknesses
7.16 BioCer Entwicklungs-GmbH.
7.16.1 BioCer Entwicklungs-GmbH. Details
7.16.2 BioCer Entwicklungs-GmbH. Major Business
7.16.3 BioCer Entwicklungs-GmbH. Hemostats Product and Services
7.16.4 BioCer Entwicklungs-GmbH. Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 BioCer Entwicklungs-GmbH. Recent Developments/Updates
7.16.6 BioCer Entwicklungs-GmbH. Competitive Strengths & Weaknesses
7.17 Biom'Up SAS
7.17.1 Biom'Up SAS Details
7.17.2 Biom'Up SAS Major Business
7.17.3 Biom'Up SAS Hemostats Product and Services
7.17.4 Biom'Up SAS Hemostats Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.17.5 Biom'Up SAS Recent Developments/Updates
7.17.6 Biom'Up SAS Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Hemostats Industry Chain
8.2 Hemostats Upstream Analysis
8.2.1 Hemostats Core Raw Materials
8.2.2 Main Manufacturers of Hemostats Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Hemostats Production Mode
8.6 Hemostats Procurement Model
8.7 Hemostats Industry Sales Model and Sales Channels
8.7.1 Hemostats Sales Model
8.7.2 Hemostats Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Hemostats Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Hemostats Production Value by Region (2019-2024) & (USD Million)
Table 3. World Hemostats Production Value by Region (2025-2030) & (USD Million)
Table 4. World Hemostats Production Value Market Share by Region (2019-2024)
Table 5. World Hemostats Production Value Market Share by Region (2025-2030)
Table 6. World Hemostats Production by Region (2019-2024) & (K Pcs)
Table 7. World Hemostats Production by Region (2025-2030) & (K Pcs)
Table 8. World Hemostats Production Market Share by Region (2019-2024)
Table 9. World Hemostats Production Market Share by Region (2025-2030)
Table 10. World Hemostats Average Price by Region (2019-2024) & (USD/Pcs)
Table 11. World Hemostats Average Price by Region (2025-2030) & (USD/Pcs)
Table 12. Hemostats Major Market Trends
Table 13. World Hemostats Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Pcs)
Table 14. World Hemostats Consumption by Region (2019-2024) & (K Pcs)
Table 15. World Hemostats Consumption Forecast by Region (2025-2030) & (K Pcs)
Table 16. World Hemostats Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Hemostats Producers in 2023
Table 18. World Hemostats Production by Manufacturer (2019-2024) & (K Pcs)
Table 19. Production Market Share of Key Hemostats Producers in 2023
Table 20. World Hemostats Average Price by Manufacturer (2019-2024) & (USD/Pcs)
Table 21. Global Hemostats Company Evaluation Quadrant
Table 22. World Hemostats Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Hemostats Production Site of Key Manufacturer
Table 24. Hemostats Market: Company Product Type Footprint
Table 25. Hemostats Market: Company Product Application Footprint
Table 26. Hemostats Competitive Factors
Table 27. Hemostats New Entrant and Capacity Expansion Plans
Table 28. Hemostats Mergers & Acquisitions Activity
Table 29. United States VS China Hemostats Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Hemostats Production Comparison, (2019 & 2023 & 2030) & (K Pcs)
Table 31. United States VS China Hemostats Consumption Comparison, (2019 & 2023 & 2030) & (K Pcs)
Table 32. United States Based Hemostats Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Hemostats Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Hemostats Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Hemostats Production (2019-2024) & (K Pcs)
Table 36. United States Based Manufacturers Hemostats Production Market Share (2019-2024)
Table 37. China Based Hemostats Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Hemostats Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Hemostats Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Hemostats Production (2019-2024) & (K Pcs)
Table 41. China Based Manufacturers Hemostats Production Market Share (2019-2024)
Table 42. Rest of World Based Hemostats Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Hemostats Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Hemostats Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Hemostats Production (2019-2024) & (K Pcs)
Table 46. Rest of World Based Manufacturers Hemostats Production Market Share (2019-2024)
Table 47. World Hemostats Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Hemostats Production by Type (2019-2024) & (K Pcs)
Table 49. World Hemostats Production by Type (2025-2030) & (K Pcs)
Table 50. World Hemostats Production Value by Type (2019-2024) & (USD Million)
Table 51. World Hemostats Production Value by Type (2025-2030) & (USD Million)
Table 52. World Hemostats Average Price by Type (2019-2024) & (USD/Pcs)
Table 53. World Hemostats Average Price by Type (2025-2030) & (USD/Pcs)
Table 54. World Hemostats Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Hemostats Production by Application (2019-2024) & (K Pcs)
Table 56. World Hemostats Production by Application (2025-2030) & (K Pcs)
Table 57. World Hemostats Production Value by Application (2019-2024) & (USD Million)
Table 58. World Hemostats Production Value by Application (2025-2030) & (USD Million)
Table 59. World Hemostats Average Price by Application (2019-2024) & (USD/Pcs)
Table 60. World Hemostats Average Price by Application (2025-2030) & (USD/Pcs)
Table 61. Ethicon Basic Information, Manufacturing Base and Competitors
Table 62. Ethicon Major Business
Table 63. Ethicon Hemostats Product and Services
Table 64. Ethicon Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Ethicon Recent Developments/Updates
Table 66. Ethicon Competitive Strengths & Weaknesses
Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Major Business
Table 69. Pfizer Hemostats Product and Services
Table 70. Pfizer Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Pfizer Recent Developments/Updates
Table 72. Pfizer Competitive Strengths & Weaknesses
Table 73. Baxter International Inc. Basic Information, Manufacturing Base and Competitors
Table 74. Baxter International Inc. Major Business
Table 75. Baxter International Inc. Hemostats Product and Services
Table 76. Baxter International Inc. Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Baxter International Inc. Recent Developments/Updates
Table 78. Baxter International Inc. Competitive Strengths & Weaknesses
Table 79. C. R. Bard Basic Information, Manufacturing Base and Competitors
Table 80. C. R. Bard Major Business
Table 81. C. R. Bard Hemostats Product and Services
Table 82. C. R. Bard Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. C. R. Bard Recent Developments/Updates
Table 84. C. R. Bard Competitive Strengths & Weaknesses
Table 85. The Medicines Company Basic Information, Manufacturing Base and Competitors
Table 86. The Medicines Company Major Business
Table 87. The Medicines Company Hemostats Product and Services
Table 88. The Medicines Company Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. The Medicines Company Recent Developments/Updates
Table 90. The Medicines Company Competitive Strengths & Weaknesses
Table 91. Anika Therapeutics Basic Information, Manufacturing Base and Competitors
Table 92. Anika Therapeutics Major Business
Table 93. Anika Therapeutics Hemostats Product and Services
Table 94. Anika Therapeutics Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Anika Therapeutics Recent Developments/Updates
Table 96. Anika Therapeutics Competitive Strengths & Weaknesses
Table 97. Advanced Medical Solutions Basic Information, Manufacturing Base and Competitors
Table 98. Advanced Medical Solutions Major Business
Table 99. Advanced Medical Solutions Hemostats Product and Services
Table 100. Advanced Medical Solutions Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Advanced Medical Solutions Recent Developments/Updates
Table 102. Advanced Medical Solutions Competitive Strengths & Weaknesses
Table 103. Integra LifeSciences Corporation Basic Information, Manufacturing Base and Competitors
Table 104. Integra LifeSciences Corporation Major Business
Table 105. Integra LifeSciences Corporation Hemostats Product and Services
Table 106. Integra LifeSciences Corporation Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Integra LifeSciences Corporation Recent Developments/Updates
Table 108. Integra LifeSciences Corporation Competitive Strengths & Weaknesses
Table 109. B Braun Melsungen AG Basic Information, Manufacturing Base and Competitors
Table 110. B Braun Melsungen AG Major Business
Table 111. B Braun Melsungen AG Hemostats Product and Services
Table 112. B Braun Melsungen AG Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. B Braun Melsungen AG Recent Developments/Updates
Table 114. B Braun Melsungen AG Competitive Strengths & Weaknesses
Table 115. Gelita Medical GmbH Basic Information, Manufacturing Base and Competitors
Table 116. Gelita Medical GmbH Major Business
Table 117. Gelita Medical GmbH Hemostats Product and Services
Table 118. Gelita Medical GmbH Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Gelita Medical GmbH Recent Developments/Updates
Table 120. Gelita Medical GmbH Competitive Strengths & Weaknesses
Table 121. Equimedical Basic Information, Manufacturing Base and Competitors
Table 122. Equimedical Major Business
Table 123. Equimedical Hemostats Product and Services
Table 124. Equimedical Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Equimedical Recent Developments/Updates
Table 126. Equimedical Competitive Strengths & Weaknesses
Table 127. Vascular Solutions Basic Information, Manufacturing Base and Competitors
Table 128. Vascular Solutions Major Business
Table 129. Vascular Solutions Hemostats Product and Services
Table 130. Vascular Solutions Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Vascular Solutions Recent Developments/Updates
Table 132. Vascular Solutions Competitive Strengths & Weaknesses
Table 133. Marine Polymer Technologies Basic Information, Manufacturing Base and Competitors
Table 134. Marine Polymer Technologies Major Business
Table 135. Marine Polymer Technologies Hemostats Product and Services
Table 136. Marine Polymer Technologies Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. Marine Polymer Technologies Recent Developments/Updates
Table 138. Marine Polymer Technologies Competitive Strengths & Weaknesses
Table 139. Z-Medica, LLC Basic Information, Manufacturing Base and Competitors
Table 140. Z-Medica, LLC Major Business
Table 141. Z-Medica, LLC Hemostats Product and Services
Table 142. Z-Medica, LLC Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. Z-Medica, LLC Recent Developments/Updates
Table 144. Z-Medica, LLC Competitive Strengths & Weaknesses
Table 145. CryoLife Basic Information, Manufacturing Base and Competitors
Table 146. CryoLife Major Business
Table 147. CryoLife Hemostats Product and Services
Table 148. CryoLife Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. CryoLife Recent Developments/Updates
Table 150. CryoLife Competitive Strengths & Weaknesses
Table 151. BioCer Entwicklungs-GmbH. Basic Information, Manufacturing Base and Competitors
Table 152. BioCer Entwicklungs-GmbH. Major Business
Table 153. BioCer Entwicklungs-GmbH. Hemostats Product and Services
Table 154. BioCer Entwicklungs-GmbH. Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 155. BioCer Entwicklungs-GmbH. Recent Developments/Updates
Table 156. Biom'Up SAS Basic Information, Manufacturing Base and Competitors
Table 157. Biom'Up SAS Major Business
Table 158. Biom'Up SAS Hemostats Product and Services
Table 159. Biom'Up SAS Hemostats Production (K Pcs), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 160. Global Key Players of Hemostats Upstream (Raw Materials)
Table 161. Hemostats Typical Customers
Table 162. Hemostats Typical Distributors
List of Figure
Figure 1. Hemostats Picture
Figure 2. World Hemostats Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Hemostats Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Hemostats Production (2019-2030) & (K Pcs)
Figure 5. World Hemostats Average Price (2019-2030) & (USD/Pcs)
Figure 6. World Hemostats Production Value Market Share by Region (2019-2030)
Figure 7. World Hemostats Production Market Share by Region (2019-2030)
Figure 8. North America Hemostats Production (2019-2030) & (K Pcs)
Figure 9. Europe Hemostats Production (2019-2030) & (K Pcs)
Figure 10. China Hemostats Production (2019-2030) & (K Pcs)
Figure 11. Japan Hemostats Production (2019-2030) & (K Pcs)
Figure 12. Hemostats Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Hemostats Consumption (2019-2030) & (K Pcs)
Figure 15. World Hemostats Consumption Market Share by Region (2019-2030)
Figure 16. United States Hemostats Consumption (2019-2030) & (K Pcs)
Figure 17. China Hemostats Consumption (2019-2030) & (K Pcs)
Figure 18. Europe Hemostats Consumption (2019-2030) & (K Pcs)
Figure 19. Japan Hemostats Consumption (2019-2030) & (K Pcs)
Figure 20. South Korea Hemostats Consumption (2019-2030) & (K Pcs)
Figure 21. ASEAN Hemostats Consumption (2019-2030) & (K Pcs)
Figure 22. India Hemostats Consumption (2019-2030) & (K Pcs)
Figure 23. Producer Shipments of Hemostats by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Hemostats Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Hemostats Markets in 2023
Figure 26. United States VS China: Hemostats Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Hemostats Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Hemostats Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Hemostats Production Market Share 2023
Figure 30. China Based Manufacturers Hemostats Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Hemostats Production Market Share 2023
Figure 32. World Hemostats Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Hemostats Production Value Market Share by Type in 2023
Figure 34. Thrombin-Based Hemostats
Figure 35. Oxidized Regenerated Cellulose Based Hemostats
Figure 36. Combination Hemostats
Figure 37. Gelatin Based Hemostats
Figure 38. Collagen Based Hemostats
Figure 39. World Hemostats Production Market Share by Type (2019-2030)
Figure 40. World Hemostats Production Value Market Share by Type (2019-2030)
Figure 41. World Hemostats Average Price by Type (2019-2030) & (USD/Pcs)
Figure 42. World Hemostats Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 43. World Hemostats Production Value Market Share by Application in 2023
Figure 44. Prehospital Treatment
Figure 45. Hospital Treatment
Figure 46. World Hemostats Production Market Share by Application (2019-2030)
Figure 47. World Hemostats Production Value Market Share by Application (2019-2030)
Figure 48. World Hemostats Average Price by Application (2019-2030) & (USD/Pcs)
Figure 49. Hemostats Industry Chain
Figure 50. Hemostats Procurement Model
Figure 51. Hemostats Sales Model
Figure 52. Hemostats Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Ethicon
Pfizer
Baxter International Inc.
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences Corporation
B Braun Melsungen AG
Gelita Medical GmbH
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica, LLC
CryoLife
BioCer Entwicklungs-GmbH.
Biom'Up SAS
jiaGou

Add To Cart

gouMai

Buy Now